Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out
in the Schedule hereto:
Active Ingredient: Alglucosidase alfa 52.5mg
Dosage Form: Powder for infusion concentrate
New Zealand Sponsor: sanofi-aventis new zealand limited
Manufacturers: Genzyme Ireland Limited, Waterford, Ireland
Hospira Inc, Kansas, United States of America
Dated this 21st day of March 2013.
DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).